SI-BONE to Truist Securities MedTech Conference on June 17, 2025

Rhea-AI Summary

SI-BONE (NASDAQ: SIBN), a medical device company focused on sacropelvic disorders, has announced its participation in the 2025 Truist Securities MedTech Conference in Boston. The company's management will conduct a fireside chat on June 17, 2025, at 10:00 a.m. PT/1:00 p.m. ET. Investors can access the live webcast by registering through a provided link or visiting the company's website's "Investors" section. The webcast recording will remain available for replay for at least 90 days following the event.

News Market Reaction – SIBN

+3.08%

1 alert

+3.08% News Effect

On the day this news was published, SIBN gained 3.08%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

SANTA CLARA, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming 2025 Truist Securities MedTech Conference in Boston, MA. Management will be hosting a fireside chat on Tuesday, June 17, 2025, at 10:00 a.m. Pacific Time/1:00 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by registering at this link: Truist Securities MedTech Conference. Live audio of the webcast will be available on the “Investors” section of the company’s website at: www.si-bone.com. The webcast will be archived and available for replay for at least 90 days after the event.

About SI-BONE, Inc.

SI-BONE (NASDAQ: SIBN) is a global leader in developing unique technologies for surgical treatment of sacropelvic disorders. Since pioneering minimally invasive SI joint surgery in 2009 with the iFuse Implant System^®, SI-BONE has supported over 4,500 physicians in performing a total of over 120,000 procedures. A unique body of clinical evidence supports the use of SI-BONE’s technologies with over 160 peer reviewed publications including two randomized controlled trials. SI-BONE has leveraged its leadership in minimally invasive SI joint fusion to commercialize novel solutions for adjacent markets, including adult deformity, spinopelvic and sacropelvic fixation and pelvic trauma.

For additional information on the company or the products, including risks and benefits, please visit www.si-bone.com.

SI-BONE, Sacropelvic Solutions, iFuse Implant System^®, iFuse Bedrock Granite, and iFuse TORQ, are registered trademarks, and iFuse 3D, iFuse TORQ TNT, and iFuse INTRA are trademarks of SI-BONE, Inc. ©2025 SI-BONE, Inc. All Rights Reserved. 

Investor Contact: Saqib Iqbal, investors@si-bone.com

FAQ

When is SI-BONE (SIBN) presenting at the Truist Securities MedTech Conference 2025?

SI-BONE will be presenting on Tuesday, June 17, 2025, at 10:00 a.m. Pacific Time/1:00 p.m. Eastern Time.

How can investors access SI-BONE's (SIBN) presentation at the Truist MedTech Conference?

Investors can access the presentation by registering through the provided link or by visiting the 'Investors' section of SI-BONE's website at www.si-bone.com.

How long will SI-BONE's (SIBN) Truist Conference presentation be available for replay?

The webcast will be archived and available for replay for at least 90 days after the event.

What type of presentation will SI-BONE (SIBN) give at the Truist Securities Conference?

SI-BONE's management will be hosting a fireside chat presentation format at the conference.